Related Experiment Videos
Two novel furan derivatives from Phellinus linteus with anti-complement activity.
Byung-Sun Min1, Bong-Sik Yun, Hyeong-Kyu Lee
1College of Pharmacy, Catholic University of Daegu, Gyeongbuk 712-702, Republic of Korea.
Bioorganic & Medicinal Chemistry Letters
|April 4, 2006
Summary
Two new furan derivatives, phellinusfurans A and B, from Phellinus linteus show significant anti-complement activity. These compounds effectively inhibit the hemolytic activity of human serum.
Area of Science:
- Natural Product Chemistry
- Immunology
- Pharmacology
Background:
- Phellinus linteus is a medicinal mushroom with various bioactive compounds.
- Furan derivatives are known for diverse biological activities.
- The complement system plays a crucial role in innate immunity and inflammation.
Purpose of the Study:
- To isolate and characterize novel furan derivatives from Phellinus linteus.
- To evaluate the anti-complement activity of the isolated compounds.
Main Methods:
- Isolation of compounds using chromatographic techniques.
- Structure elucidation through comprehensive spectroscopic analysis (e.g., NMR, MS).
- Assessment of anti-complement activity via inhibition of human serum hemolytic pathway.
Main Results:
- Two novel stereoisomers of furan derivatives, phellinusfurans A (1) and B (2), were successfully isolated.
- Compounds 1 and 2 demonstrated significant anti-complement activity.
- IC50 values for phellinusfurans A and B were determined to be 33.6 and 33.7 microM, respectively.
Conclusions:
- Phellinusfurans A and B are novel bioactive compounds with potent anti-complement properties.
- These findings suggest potential therapeutic applications for these furan derivatives in complement-mediated diseases.